Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-9.alpha.-fluoro steroids

Authors:
  • Ivan Villax
Source:
ZA 7008393

16.beta.-Methyl-17.alpha.-hydroxy-1,4,9(11)-pregnatriene-3,20-dione was treated with AcNHBr in dil. HClO4-THF to yield pregnadienedione I (R = Br, R1 = H), which underwent successive epoxidn. by NaOH and ring opening by HF in DMF to give I (R = F, R1 = H). The latter was treated with iodine, CaCl2, and CaO in MeOH at 25.degree. to give I (R = F, R1 = iodo), which was refluxed with KOAc in Me2Co to give betamethasone acetate in 63.3% overall yield.

Also in the Knowledge Center

Related Content

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Hovione Policies

Hovione is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page
Read more

Drug Substance Technologies

We constantly innovate to find better, more efficient ways of doing things.

Page
Read more